Axe Compute Inc. (AGPU) - Total Liabilities
Based on the latest financial reports, Axe Compute Inc. (AGPU) has total liabilities worth $5.17 Million USD as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Axe Compute Inc. net asset momentum to track the company's year-over-year net asset growth rate.
Axe Compute Inc. - Total Liabilities Trend (2008–2025)
This chart illustrates how Axe Compute Inc.'s total liabilities have evolved over time, based on quarterly financial data.
Axe Compute Inc. Competitors by Total Liabilities
The table below lists competitors of Axe Compute Inc. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Pardus Girisim Sermayesi Yatirim Ortakligi A.S.
IS:PRDGS
|
Turkey | TL1.02 Million |
|
GoviEx Uranium Inc
V:GXU
|
Canada | CA$2.20 Million |
|
Zedge Inc
NYSE MKT:ZDGE
|
USA | $9.75 Million |
|
Atlantic American Corporation
NASDAQ:AAME
|
USA | $321.37 Million |
|
EDM Resources Inc
V:EDM
|
Canada | CA$15.43 Million |
|
Denge Yatirim Holding AS
IS:DENGE
|
Turkey | TL576.37 Million |
|
Remsons Industries Limited
NSE:REMSONSIND
|
India | Rs2.09 Billion |
|
Groupe Canal Plus
LSE:CAN
|
UK | GBX3.80 Billion |
Liability Composition Analysis (2008–2025)
This chart breaks down Axe Compute Inc.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is Axe Compute Inc. worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 10.02 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.11 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.10 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Axe Compute Inc.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Axe Compute Inc. (2008–2025)
The table below shows the annual total liabilities of Axe Compute Inc. from 2008 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $5.17 Million | -0.07% |
| 2024-12-31 | $5.18 Million | -15.79% |
| 2023-12-31 | $6.15 Million | +54.85% |
| 2022-12-31 | $3.97 Million | +13.21% |
| 2021-12-31 | $3.51 Million | -66.35% |
| 2020-12-31 | $10.42 Million | -6.52% |
| 2019-12-31 | $11.14 Million | +204.86% |
| 2018-12-31 | $3.66 Million | +292.08% |
| 2017-12-31 | $932.34K | -50.51% |
| 2016-12-31 | $1.88 Million | +23.96% |
| 2015-12-31 | $1.52 Million | -76.32% |
| 2014-12-31 | $6.42 Million | +68.35% |
| 2013-12-31 | $3.81 Million | +3.79% |
| 2012-12-31 | $3.67 Million | +16.62% |
| 2011-12-31 | $3.15 Million | +33.71% |
| 2010-12-31 | $2.36 Million | -10.52% |
| 2009-12-31 | $2.63 Million | +139.65% |
| 2008-12-31 | $1.10 Million | -- |
About Axe Compute Inc.
Axe Compute Inc. provides access to graphics processing unit and digital asset treasury strategy. The company operates through two segments: Compute Services and Treasury Management; and Drug Discovery Services. The Compute Services and Treasury Management segment provides access to graphics processing unit compute capacity and digital asset treasury strategy focused on Aethir token. The Drug Dis… Read more